Multiply Labs

Robotic production capacity for the pharma manufacturing industry

San Francisco, United States · Founded 2016 · $43.4M raised

Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$43.4M
Last Round
$9.5M Series BMar 2026
Rounds
4

About

The traditional manufacturing process for individualized drugs is extremely slow and expensive, because it is based on manual labor. At Multiply Labs, we believe that robotics is the only way to truly scale the production of individualized drugs - finally providing these life-saving therapies to the millions of patients who need them. We develop cloud-controlled modular robotic systems that manufacture individualized drugs, and we deploy these systems in the facilities of our pharma customers. This is pharma robotics as a service: we sell the robotic production capacity that our customers need to scale their next-gen individualized drugs.

Summary

Multiply Labs is an Industrials company based in San Francisco, United States, founded in 2016. It has raised $43.4M in total across 4 rounds, most recently a $9.5M Series B round in Mar 2026. Investors include Mayfield Fund, Casdin Capital and Y Combinator Continuity Fund.

Tech & App Stack

5 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series BSeries B (AI Advertising - Multiply)Mar 2026
$9.5M

Sign up to see all 4 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies